Urology
Volume 75, Issue 2 , Pages 414-418 , February 2010

Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Protocols

  • C. Shad Thaxton

      Affiliations

    • Department of Urology, Northwestern Feinberg School of Medicine, Chicago, Illinois
    • Robert H. Lurie Comprehensive Cancer Center, Northwestern Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Stacy Loeb

      Affiliations

    • Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland
    • ,
  • Kimberly A. Roehl

      Affiliations

    • Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Donghui Kan

      Affiliations

    • Department of Urology, Northwestern Feinberg School of Medicine, Chicago, Illinois
    • ,
  • William J. Catalona

      Affiliations

    • Department of Urology, Northwestern Feinberg School of Medicine, Chicago, Illinois
    • Robert H. Lurie Comprehensive Cancer Center, Northwestern Feinberg School of Medicine, Chicago, Illinois
    • Corresponding Author InformationReprint requests: William J. Catalona, M.D., Robert H. Lurie Comprehensive Cancer Center, Northwestern Feinberg School of Medicine, 675 N St Clair, Suite 20–150, Chicago, IL 60611

Received 6 May 2009 ,Accepted 20 July 2009.

References 

  1. American Cancer Society. Cancer facts and figures 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdfAccessed March 5, 2008
  2. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  3. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242–248
  4. Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713–2719
  5. Bill-Axelson A, Holmberg L, Filen F, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144–1154
  6. Carter HB, Kettermann A, Warlick C, et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol. 2007;178:2359–2364discussion:2364-2365
  7. Dall'Era MA, Cooperberg MR, Chan JM, et al. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008;112:1650–1659
  8. Conti SL, Dall'era M, Fradet V, et al. pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009;181:1628–1633discussion:1633-1634
  9. Patel MI, DeConcini DT, Lopez-Corona E, et al. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol. 2004;171:1520–1524
  10. Choo R, Klotz L, Danjoux C, et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167:1664–1669
  11. Mohler JL, Williams BT, Freeman JA. Expectant management as an option for men with stage T1c prostate cancer: a preliminary study. World J Urol. 1997;15:364–368
  12. Bastian PJ, Mangold LA, Epstein JI, et al. Characteristics of insignificant clinical T1c prostate tumors (A contemporary analysis). Cancer. 2004;101:2001–2005
  13. Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol. 2003;170:1792–1797
  14. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol. 2005;23:8165–8169
  15. Suardi N, Capitanio U, Chun FK, et al. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features. Cancer. 2008;113:2068–2072
  16. Freedland SJ, Kane CJ, Amling CL, et al. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. J Urol. 2006;175:1298–1302discussion:1302-1303
  17. Warlick C, Trock BJ, Landis P, et al. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst. 2006;98:355–357
  18. Loeb S, Roehl KA, Helfand BT, et al. Complications of open radical retropubic prostatectomy in potential candidates for active monitoring. Urology. 2008;72:887–891
  19. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368–374
  20. Griffin CR, Yu X, Loeb S, et al. Pathological features after radical prostatectomy in potential candidates for active monitoring. J Urol. 2007;178:860–863discussion:863

 Supported by the Urological Research Foundation, Beckman Coulter, Inc., the Prostate SPORE grant (P50 CA90386-05S2) and the Robert H. Lurie Comprehensive Cancer Center grant (P30 CA60553) (to (W.J.C.).

PII: S0090-4295(09)02612-0

doi: 10.1016/j.urology.2009.07.1353

Urology
Volume 75, Issue 2 , Pages 414-418 , February 2010

Article Tools

* Image Usage & Resolution